Min Li,Liu Yuliang,Xu Yu,Li Wancheng,Chen Hong.Expression profiles of T cell factor 3 in non-small cell lung cancer tissues[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(05):425-428.
Min Li,Liu Yuliang,Xu Yu,Li Wancheng,Chen Hong.Expression profiles of T cell factor 3 in non-small cell lung cancer tissues[J].J Amry Med Univ (J Third Mil Med Univ),2015,37(05):425-428.DOI:
Expression profiles of T cell factor 3 in non-small cell lung cancer tissues
Objective To determine the expression profiles and distribution of T cell factor-3 (TCF-3) in non-small cell lung cancer (NSCLC). Methods TCF-3 expression was examined in 50 NSCLC tissue specimens and their corresponding normal lung specimens by immunohistochemical assay (S-P method). The mRNA levels of TCF-3 were detected in 5 cell lines of NSCLC (A549
H460
H226
H520 and SK-MES-1 cell lines ) and 2 human normal bronchial epithelial cell lines (HBE and BEP-2D cell lines) by real-time fluorescence quantitative PCR. The protein level of TCF-3 gene in the cell lines was detected by Western blotting. Results Among the 50 lung cancer specimens
24 samples showed high expression of TCF-3 (48%)
and 22 samples had the expression both in the cytoplasm and nuclei. But no TCF-3 expression was detected in 50 corresponding normal lung specimens. The expression of TCF-3 was found at mRNA and protein levels in the cell lines A549
H520
HBE
and BEP-2D. Conclusion TCF-3 is expressed in the NSCLC tissue as well as cell lines. TCF-3 protein is located in the nuclei and cytoplasm
Integrative model combining deep learning, clinical and radiomic features enhances EGFR mutation prediction in non-small cell lung cancer
Preparation of doxorubicin-loaded polyphyllin H liposomes and synergistic anti-tumor activity against non-small cell lung cancer in vitro
Development of a postoperative recurrence prediction model for stage Ⅰ non-small cell lung cancer patients using multimodal data based on machine learning
Effect of chronic obstructive pulmonary disease on immunotherapy in patients with advanced non-small cell lung cancer
Efficacy and resistance of EGFR-TKIs for first-line treatment for compound EGFR mutations positive non-small cell lung cancer
Related Author
YANG Taotao
CHEN Wei
CHEN Cancan
YAN Wanying
WANG Dawei
XIONG Kunlin
SUN Zhiyuan
WANG Xianqi
Related Institution
Department of Radiology,First Affiliated Hospital, Army Medical University (Third Military Medical University)
Infervision Medical Technology Co., Ltd
Department of Radiology, Daping Hospital, Army Medical University
Department of Diagnostic Radiology, Eastern Theatre General Hospital
Department of Medical Service,No. Hospital of Joint Logistics Support Force